(Q61980521)
Statements
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of SLx-4090 in Combination With Metformin in Subjects With Type 2 Diabetes (English)
0 references
April 2009
0 references
October 2009
0 references
82
0 references
18 year
0 references
75 year
0 references